Matthew Garlinghouse, Ph.D., an assistant professor of neurological sciences at the University of Nebraska at Omaha, will discuss the medical science findings surrounding the use of cannabis and CBD at the Nov. 5 Omaha Science Café at 7 p.m. at the Slowdown, 729 N. 14th St.
Dr. Garlinghouse completed his doctoral degree in clinical neuropsychology at the University of North Dakota. He completed his internship and two-year fellowship in clinical neuropsychology at Dartmouth Medical School (now Geisel School of Medicine at Dartmouth), in Hanover, New Hampshire.
He then subsequently completed a two-year research fellowship in neuroimaging. He has been faculty at Harvard Medical School and Wayne State School of Medicine.
Dr. Garlinghouse’s clinical practice involves assessing patients with cancer and seizure disorder, as well as psychiatric disorders. His research interests have included using varying neuroimaging techniques to evaluate the effects of cannabis on brain reward circuitry and general brain structure.
Science Cafés involve a face-to-face conversation with a scientist about current science topics. They are open to everyone (21 and older) and take place in casual settings like pubs and coffeehouses. Each meeting is organized around an interesting topic of conversation. A scientist gives a brief presentation followed by a Q-and-A period.
Pizza will be provided for the first 50 people. For more information about Science Cafes, go to www.unmc.edu/sciencecafe.
We are Nebraska Medicine and UNMC. Our mission is to lead the world in transforming lives to create a healthy future for all individuals and communities through premier educational programs, innovative research and extraordinary patient care.
Twitter | Facebook | Instagram | YouTube | Flickr
Cannabis in Colorado is topic of Omaha Science Cafe on Nov. 5
